Investor: Andrew Spokes
Number of Assets: 172
Reporting Period: Q1 - 2026
Holdings at Report: $17,542,713,843
Return Since Report: +$682,812,918
Return Since Report: +3.89%
Company | Position | Activity | Shares | Port. % | Rep. Price | Curr. Price | Rep. Value | Curr. Value | Return Value | Return % |
|---|---|---|---|---|---|---|---|---|---|---|
| Affirm Holdings Inc. (AFRM) | Equity | +100% | 108,000 | 0.03% | $45.82 | $65.82 | $4,948,560 | $7,108,560 | +$2,160,000 | +43.65% |
| Amicus Therapeutics Inc. (FOLD) | Equity | 0% | 16,000 | 0.00% | $14.46 | $14.49 | $231,360 | $231,840 | +$480 | +0.21% |
| Apellis Pharmaceuticals Inc. (APLS) | Equity | +100% | 6,000 | 0.00% | $40.23 | N/A | $241,380 | N/A | N/A | N/A |
| Acadia Healthcare Company Inc. (ACHC) | Equity | +100% | 1,736,800 | 0.23% | $23.39 | $25.81 | $40,623,752 | $44,826,808 | +$4,203,056 | +10.35% |
| Adaptive Biotechnologies Corp. (ADPT) | Equity | 0% | 11,000 | 0.00% | $13.88 | $12.83 | $152,680 | $141,130 | -$11,550 | -7.56% |
| Alphabet Inc. (GOOG) | Equity | +26.58% | 996,231 | 1.64% | $286.86 | $393.32 | $285,778,825 | $391,837,577 | +$106,058,752 | +37.11% |
| Altimmune Inc. (ALT) | Equity | 0% | 27,600 | 0.00% | $3.08 | $2.85 | $85,008 | $78,660 | -$6,348 | -7.47% |
| Amazon.com Inc. (AMZN) | Equity | -6.26% | 4,218,394 | 5.03% | $208.27 | $264.14 | $878,564,918 | $1,114,246,591 | +$235,681,673 | +26.83% |
| Aon PLC (AON) | Equity | -5.73% | 2,512,638 | 4.64% | $322.78 | $317.27 | $811,029,294 | $797,184,658 | -$13,844,636 | -1.71% |
| Assembly Biosciences Inc. (ASMB) | Equity | 0% | 1,227,590 | 0.20% | $27.75 | N/A | $34,065,623 | N/A | N/A | N/A |
| Atrium Therapeutics INC | Equity | +100% | 349,360 | 0.03% | $13.37 | N/A | $4,670,943 | N/A | N/A | N/A |
| Axsome Therapeutics Inc. (AXSM) | Equity | 0% | 4,000 | 0.00% | $169.02 | $227.72 | $676,080 | $910,880 | +$234,800 | +34.73% |
| Beyond Meat Inc. (BYND) | Equity | 0% | 19,000 | 0.00% | $0.70 | $0.80 | $13,330 | $15,276 | +$1,946 | +14.60% |
| Biocryst Pharmaceuticals Inc. (BCRX) | Equity | 0% | 24,000 | 0.00% | $9.52 | $9.02 | $228,480 | $216,480 | -$12,000 | -5.25% |
| Bitwise 10 Crypto Index ETF | Equity | -82.19% | 603,000 | 0.15% | $44.61 | N/A | $26,898,021 | N/A | N/A | N/A |
| Blue Gold LTD | Warrant | +100% | 300,000 | N/A | $0.20 | N/A | $60,000 | N/A | N/A | N/A |
| Citigroup Inc. (C) | Equity | +100% | 47,000 | 0.03% | $113.41 | $123.42 | $5,330,270 | $5,800,740 | +$470,470 | +8.83% |
| Cogent Biosciences Inc. (COGT) | Equity | 0% | 17,000 | 0.00% | $38.49 | $32.68 | $654,330 | $555,560 | -$98,770 | -15.09% |
| Crinetics Pharmaceuticals Inc. (CRNX) | Equity | +20.27% | 8,338,098 | 1.73% | $36.32 | $36.77 | $302,839,719 | $306,591,863 | +$3,752,144 | +1.24% |
| Cummins Inc. (CMI) | Equity | +100% | 9,000 | 0.03% | $538.02 | $696.90 | $4,842,180 | $6,272,100 | +$1,429,920 | +29.53% |
| Dyne Therapeutics Inc. (DYN) | Equity | 0% | 10,000 | 0.00% | $18.13 | $17.29 | $181,300 | $172,900 | -$8,400 | -4.63% |
| Enanta Pharmaceuticals Inc. (ENTA) | Equity | +3.59% | 2,871,862 | 0.21% | $12.63 | $13.41 | $36,271,617 | $38,511,669 | +$2,240,052 | +6.18% |
| Encompass Health Corp. (EHC) | Equity | -98.72% | 3,000 | 0.00% | $96.73 | $106.64 | $290,190 | $319,920 | +$29,730 | +10.25% |
| Erasca Inc. (ERAS) | Equity | +100% | 18,000 | 0.00% | $16.18 | N/A | $291,240 | N/A | N/A | N/A |
| Evolent Health Inc. (EVH) | Equity | 0% | 14,000 | 0.00% | $2.28 | $3.96 | $31,920 | $55,440 | +$23,520 | +73.68% |
| GDS Holdings Limited (GDS) | Equity | +100% | 292,000 | 0.07% | $40.29 | $42.44 | $11,764,680 | $12,392,480 | +$627,800 | +5.34% |
| Healthcare Realty Trust Inc. (HR) | Equity | 0% | 12,000 | 0.00% | $16.99 | $20.29 | $203,880 | $243,480 | +$39,600 | +19.42% |
| Healthequity Inc. (HQY) | Equity | -44.00% | 2,800 | 0.00% | $83.57 | $82.17 | $233,996 | $230,076 | -$3,920 | -1.68% |
| Hims & Hers Health Inc. (HIMS) | Equity | -99.70% | 10,000 | 0.00% | $20.76 | $25.05 | $207,600 | $250,500 | +$42,900 | +20.66% |
| Hyatt Hotels Corp. (H) | Equity | +100% | 36,000 | 0.03% | $143.79 | $168.78 | $5,176,440 | $6,076,080 | +$899,640 | +17.38% |
| Inter & CO INC | Equity | +100% | 614,500 | 0.03% | $7.96 | N/A | $4,891,420 | N/A | N/A | N/A |
| Johnson & Johnson (JNJ) | Equity | +100% | 148,000 | 0.21% | $244.44 | $226.71 | $36,177,120 | $33,553,080 | -$2,624,040 | -7.25% |
| Liquidia Corp. (LQDA) | Equity | 0% | 8,656,038 | 1.87% | $37.74 | $56.93 | $326,678,874 | $492,788,243 | +$166,109,369 | +50.85% |
| AAR Corp. (AIR) | Equity | +100% | 46,000 | 0.03% | $109.46 | N/A | $5,035,160 | N/A | N/A | N/A |
| Abivax Société Anonyme (ABVX) | Equity | -99.48% | 2,000 | 0.00% | $111.35 | N/A | $222,700 | N/A | N/A | N/A |
| Agios Pharmaceuticals Inc. (AGIO) | Equity | +10.17% | 5,684,000 | 1.10% | $33.83 | $28.17 | $192,289,720 | $160,118,280 | -$32,171,440 | -16.73% |
| Aleanna Inc. | Warrant | +100% | 990,000 | N/A | $0.81 | N/A | $801,900 | N/A | N/A | N/A |
| Aleanna Inc. (ANNA) | Equity | 0% | 78,400 | 0.00% | $8.29 | $3.43 | $649,936 | $268,912 | -$381,024 | -58.62% |
| Alkermes PLC (ALKS) | Equity | 0% | 20,800 | 0.00% | $35.36 | $37.48 | $735,488 | $779,584 | +$44,096 | +6.00% |
| Alumis Inc. (ALMS) | Equity | +100% | 11,000 | 0.00% | $22.03 | N/A | $242,330 | N/A | N/A | N/A |
| Alvotech (ALVO) | Equity | 0% | 199,675 | 0.00% | $3.43 | $3.31 | $684,885 | $660,924 | -$23,961 | -3.50% |
| Amkor Technology Inc. (AMKR) | Equity | -77.59% | 104,000 | 0.03% | $45.03 | N/A | $4,683,120 | N/A | N/A | N/A |
| Arrowhead Pharmaceuticals Inc. (ARWR) | Equity | 0% | 15,800 | 0.01% | $62.70 | $76.67 | $990,660 | $1,211,386 | +$220,726 | +22.28% |
| Avalo Therapeutics Inc. (AVTX) | Equity | +100% | 916,000 | 0.08% | $14.93 | N/A | $13,675,880 | N/A | N/A | N/A |
| Belite Bio inc (BLTE) | Equity | +100% | 1,300 | 0.00% | $159.44 | N/A | $207,272 | N/A | N/A | N/A |
| Beigene Ltd (ONC) | Equity | 0% | 1,100 | 0.00% | $296.97 | $316.90 | $326,667 | $348,590 | +$21,923 | +6.71% |
| Beta Bionics Inc. (BBNX) | Equity | -16.37% | 3,607,920 | 0.21% | $10.02 | $9.46 | $36,151,358 | $34,130,923 | -$2,020,435 | -5.59% |
| Broadcom Inc. (AVGO) | Equity | +99.41% | 1,779,500 | 3.15% | $309.51 | $425.19 | $550,773,045 | $756,625,605 | +$205,852,560 | +37.38% |
| C4 Therapeutics Inc. (CCCC) | Equity | 0% | 28,000 | 0.00% | $2.63 | $3.56 | $73,640 | $99,680 | +$26,040 | +35.36% |
| Canopy Growth Corp. (CGC) | Equity | 0% | 30,000 | 0.00% | $0.95 | $1.04 | $28,476 | $31,200 | +$2,724 | +9.57% |
| Capricor Therapeutics Inc. (CAPR) | Equity | 0% | 41,000 | 0.01% | $30.40 | $28.79 | $1,246,400 | $1,180,390 | -$66,010 | -5.30% |
| Cardinal Health Inc. (CAH) | Equity | -36.11% | 368,000 | 0.45% | $211.31 | $195.20 | $77,762,080 | $71,833,600 | -$5,928,480 | -7.62% |
| Ceco Environmental Corp. (CECO) | Equity | +100% | 234,000 | 0.08% | $59.58 | $51.19 | $13,941,720 | $11,978,460 | -$1,963,260 | -14.08% |
| Celcuity Inc. (CELC) | Equity | 0% | 4,000 | 0.00% | $114.14 | N/A | $456,560 | N/A | N/A | N/A |
| Cencora Inc. (COR) | Equity | 0% | 1,000 | 0.00% | $314.14 | $257.71 | $314,140 | $257,710 | -$56,430 | -17.96% |
| Centessa Pharmaceuticals PLC (CNTA) | Equity | -10.56% | 4,809,000 | 1.09% | $39.72 | $39.59 | $191,013,480 | $190,388,310 | -$625,170 | -0.33% |
| CG Oncology Inc. (CGON) | Equity | +8325.00% | 674,000 | 0.26% | $67.68 | $66.93 | $45,616,320 | $45,110,820 | -$505,500 | -1.11% |
| The Walt Disney Company (DIS) | Equity | -41.79% | 2,401,591 | 1.33% | $96.38 | $102.72 | $231,465,341 | $246,691,428 | +$15,226,087 | +6.58% |
| Fiserv Inc. (FISV) | Equity | +100% | 86,000 | 0.03% | $55.80 | $55.33 | $4,798,800 | $4,758,380 | -$40,420 | -0.84% |
| Flex Ltd. (FLEX) | Equity | +100% | 78,000 | 0.03% | $65.46 | $137.86 | $5,105,880 | $10,753,080 | +$5,647,200 | +110.60% |
| Formfactor Inc. (FORM) | Equity | +100% | 56,500 | 0.03% | $96.99 | $126.27 | $5,479,935 | $7,134,255 | +$1,654,320 | +30.19% |
| Garrett Motion Inc. (GTX) | Equity | +100% | 275,000 | 0.03% | $18.17 | $30.98 | $4,996,750 | $8,519,500 | +$3,522,750 | +70.50% |
| Grail Inc. (GRAL) | Equity | +38.89% | 3,253,684 | 0.96% | $51.68 | $59.65 | $168,150,389 | $194,082,251 | +$25,931,862 | +15.42% |
| Grifols S.A. (GRFS) | Equity | 0% | 28,000 | 0.00% | $8.02 | $7.66 | $224,560 | $214,480 | -$10,080 | -4.49% |
| Guardant Health Inc. (GH) | Equity | -92.66% | 8,000 | 0.00% | $92.37 | $94.92 | $738,960 | $759,360 | +$20,400 | +2.76% |
| Invesco Exchange Traded FD T | Equity | +100% | 3,600,000 | 3.96% | $191.92 | N/A | $690,912,000 | N/A | N/A | N/A |
| Ionis Pharmaceuticals Inc. (IONS) | Equity | 0% | 4,800 | 0.00% | $75.09 | N/A | $360,432 | N/A | N/A | N/A |
| Iovance Biotherapeutics Inc. (IOVA) | Equity | 0% | 26,000 | 0.00% | $3.51 | $3.45 | $91,260 | $89,700 | -$1,560 | -1.71% |
| Ironwood Pharmaceuticals Inc. (IRWD) | Equity | 0% | 13,000 | 0.00% | $3.51 | $1.54 | $45,630 | $19,955 | -$25,675 | -56.27% |
| Krystal Biotech Inc. (KRYS) | Equity | -50.00% | 1,000 | 0.00% | $258.32 | $306.29 | $258,320 | $306,290 | +$47,970 | +18.57% |
| Lantheus Holdings Inc. (LNTH) | Equity | +2.87% | 5,583,479 | 2.43% | $75.85 | $93.91 | $423,506,882 | $524,344,513 | +$100,837,631 | +23.81% |
| Mastec Inc. (MTZ) | Equity | +100% | 17,000 | 0.03% | $321.74 | $414.90 | $5,469,580 | $7,053,300 | +$1,583,720 | +28.96% |
| Mckesson Corp. (MCK) | Equity | -21.61% | 234,300 | 1.16% | $865.36 | $760.57 | $202,753,848 | $178,201,551 | -$24,552,297 | -12.11% |
| Molina Healthcare Inc. (MOH) | Equity | +100% | 35,000 | 0.03% | $133.30 | $184.95 | $4,665,500 | $6,473,250 | +$1,807,750 | +38.75% |
| Novavax Inc. (NVAX) | Equity | -88.72% | 22,000 | 0.00% | $8.14 | $9.06 | $179,080 | $199,320 | +$20,240 | +11.30% |
| Revolution Medicines Inc. (RVMD) | Equity | -6.71% | 13,604,796 | 7.58% | $97.25 | $49.16 | $1,323,066,411 | $668,811,771 | -$654,254,640 | -49.45% |
| Royalty Pharma PLC (RPRX) | Equity | +100% | 493,000 | 0.14% | $47.97 | $52.85 | $23,649,210 | $26,055,050 | +$2,405,840 | +10.17% |
| The Charles Schwab Corp. (SCHW) | Equity | +18.45% | 3,955,657 | 2.13% | $93.98 | $90.89 | $371,752,645 | $359,529,665 | -$12,222,980 | -3.29% |
| Servicenow Inc. (NOW) | Equity | +100% | 41,000 | 0.02% | $104.55 | $95.07 | $4,286,550 | $3,897,870 | -$388,680 | -9.07% |
| Solid Power Inc. (SLDPW) | Warrant | +100% | 405,316 | N/A | $0.22 | N/A | $88,359 | N/A | N/A | N/A |
| SPDR S&P 500 ETF Tr (SPY) | Equity | +100% | 2,300,000 | 8.56% | $650.34 | N/A | $1,495,782,000 | N/A | N/A | N/A |
| Terns Pharmaceuticals Inc. (TERN) | Equity | -98.91% | 7,000 | 0.00% | $52.72 | N/A | $369,040 | N/A | N/A | N/A |
| Twist Bioscience Corp. (TWST) | Equity | +18562.09% | 1,427,650 | 0.39% | $47.52 | $49.17 | $67,841,928 | $70,197,551 | +$2,355,623 | +3.47% |
| Tyra Biosciences Inc. (TYRA) | Equity | +73.25% | 3,580,818 | 0.79% | $38.30 | $37.04 | $137,145,329 | $132,633,499 | -$4,511,830 | -3.29% |
| Uniqure N.V. (QURE) | Equity | 0% | 14,000 | 0.00% | $16.35 | $27.05 | $228,900 | $378,700 | +$149,800 | +65.44% |
| Aramark (ARMK) | Equity | -34.43% | 6,135,431 | 1.42% | $40.54 | $53.08 | $248,730,373 | $325,668,677 | +$76,938,304 | +30.93% |
| Arcutis Biotherapeutics Inc. (ARQT) | Equity | 0% | 26,000 | 0.00% | $23.56 | $21.32 | $612,560 | $554,320 | -$58,240 | -9.51% |
| Ardelyx Inc. (ARDX) | Equity | 0% | 23,000 | 0.00% | $5.99 | $6.23 | $137,770 | $143,290 | +$5,520 | +4.01% |
| Astrazeneca PLC | Equity | +100% | 226,499 | 0.26% | $197.22 | N/A | $44,670,133 | N/A | N/A | N/A |
| Baidu Inc. (BIDU) | Equity | +40.75% | 443,785 | 0.28% | $111.42 | $135.33 | $49,446,525 | $60,057,424 | +$10,610,899 | +21.46% |
| Beam Therapeutics Inc. (BEAM) | Equity | +0.71% | 10,134,696 | 1.38% | $23.83 | $27.93 | $241,509,806 | $283,062,059 | +$41,552,253 | +17.21% |
| Boston Scientific Corp. (BSX) | Equity | +0.42% | 7,470,684 | 2.68% | $62.75 | $52.70 | $468,785,421 | $393,705,047 | -$75,080,374 | -16.02% |
| Bridgebio Pharma Inc. (BBIO) | Equity | +4.08% | 9,365,463 | 3.98% | $74.26 | $66.13 | $695,479,282 | $619,338,068 | -$76,141,214 | -10.95% |
| Brightspring Health Services Inc. (BTSG) | Equity | +7250.00% | 1,617,000 | 0.39% | $42.61 | $57.90 | $68,900,370 | $93,624,300 | +$24,723,930 | +35.88% |
| CG Oncology INC | Equity | +100% | 200,000 | 0.08% | $67.68 | N/A | $13,536,000 | N/A | N/A | N/A |
| Dianthus Therapeutics Inc. (DNTH) | Equity | +100% | 836,000 | 0.40% | $83.92 | N/A | $70,157,120 | N/A | N/A | N/A |
| Entegris Inc. (ENTG) | Equity | +100% | 45,500 | 0.03% | $117.24 | $133.07 | $5,334,420 | $6,054,685 | +$720,265 | +13.50% |
| Exelixis Inc. (EXEL) | Equity | -16.54% | 13,111,010 | 3.22% | $42.89 | $50.13 | $562,331,219 | $657,254,931 | +$94,923,712 | +16.88% |
| GE Healthcare Technologies Inc. (GEHC) | Equity | 0% | 3,000 | 0.00% | $71.18 | $60.76 | $213,540 | $182,280 | -$31,260 | -14.64% |
| Genedx Holdings Corp. (WGS) | Equity | -92.86% | 5,000 | 0.00% | $64.22 | $40.75 | $321,100 | $203,750 | -$117,350 | -36.55% |
| Geron Corp. (GERN) | Equity | 0% | 43,000 | 0.00% | $1.49 | $1.29 | $64,070 | $55,470 | -$8,600 | -13.42% |
| Glaukos Corp. (GKOS) | Equity | 0% | 2,600 | 0.00% | $107.66 | $144.01 | $279,916 | $374,426 | +$94,510 | +33.76% |
| Globalfoundries Inc. (GFS) | Equity | +100% | 105,000 | 0.03% | $44.48 | N/A | $4,670,400 | N/A | N/A | N/A |
| Globus Medical Inc. (GMED) | Equity | 0% | 4,000 | 0.00% | $86.16 | $76.64 | $344,640 | $306,560 | -$38,080 | -11.05% |
| Immunovant Inc. (IMVT) | Equity | +12783.33% | 1,546,000 | 0.22% | $24.84 | $27.49 | $38,402,640 | $42,499,540 | +$4,096,900 | +10.67% |
| Joyy Inc. (YY) | Equity | 0% | 578,200 | 0.19% | $58.39 | $57.35 | $33,761,098 | $33,159,770 | -$601,328 | -1.78% |
| KKR & Co. Inc. (KKR) | Equity | +131.54% | 4,671,800 | 2.47% | $92.50 | $96.97 | $432,141,500 | $453,024,446 | +$20,882,946 | +4.83% |
| Madrigal Pharmaceuticals Inc. (MDGL) | Equity | 0% | 3,319 | 0.01% | $523.47 | $523.69 | $1,737,397 | $1,738,127 | +$730 | +0.04% |
| Maze Therapeutics Inc. (MAZE) | Equity | +100% | 373,000 | 0.06% | $29.85 | N/A | $11,134,050 | N/A | N/A | N/A |
| Microsoft Corp. (MSFT) | Equity | +5.90% | 2,344,779 | 4.97% | $370.17 | $421.92 | $867,966,842 | $989,309,156 | +$121,342,314 | +13.98% |
| Minerva Neurosciences Inc. (NERV) | Equity | 0% | 2,365,000 | 0.08% | $6.03 | N/A | $14,249,125 | N/A | N/A | N/A |
| Mirum Pharmaceuticals Inc. (MIRM) | Equity | 0% | 3,000 | 0.00% | $92.38 | $102.19 | $277,140 | $306,555 | +$29,415 | +10.61% |
| Netease Inc. (NTES) | Equity | +100% | 291,219 | 0.19% | $111.94 | $113.38 | $32,599,055 | $33,018,410 | +$419,355 | +1.29% |
| Nuvation Bio Inc. (NUVB) | Equity | 0% | 29,000 | 0.00% | $4.29 | $4.32 | $124,410 | $125,280 | +$870 | +0.70% |
| NVNI Group Limited | Warrant | +100% | 375,000 | N/A | $0.05 | N/A | $17,813 | N/A | N/A | N/A |
| Ocular Therapeutix Inc. (OCUL) | Equity | 0% | 18,000 | 0.00% | $8.47 | N/A | $152,460 | N/A | N/A | N/A |
| Omeros Corporation (OMER) | Equity | 0% | 23,000 | 0.00% | $10.56 | N/A | $242,880 | N/A | N/A | N/A |
| Oscar Health Inc. (OSCR) | Equity | -95.83% | 11,000 | 0.00% | $11.47 | $23.32 | $126,170 | $256,520 | +$130,350 | +103.31% |
| Pacific Biosciences Of California Inc. (PACB) | Equity | 0% | 135,000 | 0.00% | $1.32 | $1.12 | $178,200 | $151,200 | -$27,000 | -15.15% |
| Perceptive Capital Solutions corp (PCSC) | Equity | 0% | 2,250,000 | 0.14% | $10.97 | N/A | $24,682,500 | N/A | N/A | N/A |
| Protagonist Therapeutics Inc. (PTGX) | Equity | +3.33% | 6,348,906 | 3.83% | $105.40 | $102.18 | $669,174,692 | $648,731,215 | -$20,443,477 | -3.06% |
| Rani Therapeutics Holdings Inc. (RANI) | Equity | 0% | 78,000 | 0.00% | $0.73 | N/A | $57,314 | N/A | N/A | N/A |
| Revolution Medicines Inc. (RVMDW) | Warrant | +100% | 120,085 | N/A | $1.74 | N/A | $208,948 | N/A | N/A | N/A |
| Roivant Sciences Ltd. (ROIV) | Equity | +26048.65% | 9,675,000 | 1.53% | $27.70 | $29.29 | $267,997,500 | $283,380,750 | +$15,383,250 | +5.74% |
| Rollins Inc. (ROL) | Equity | +100% | 93,000 | 0.03% | $53.41 | $53.42 | $4,967,130 | $4,967,595 | +$465 | +0.01% |
| Sabra Health Care Reit Inc. (SBRA) | Equity | 0% | 14,000 | 0.00% | $19.23 | $20.67 | $269,220 | $289,380 | +$20,160 | +7.49% |
| Scholar Rock Holding Corp. (SRRK) | Equity | 0% | 7,000 | 0.00% | $49.16 | $49.35 | $344,120 | $345,450 | +$1,330 | +0.39% |
| Schrödinger Inc. (SDGR) | Equity | -76.06% | 17,000 | 0.00% | $11.36 | $11.95 | $193,120 | $203,150 | +$10,030 | +5.19% |
| Sellas Life Sciences Group Inc. (SLS) | Equity | +100% | 40,000 | 0.00% | $4.23 | N/A | $169,200 | N/A | N/A | N/A |
| Synopsys Inc. (SNPS) | Equity | +21.43% | 1,213,300 | 2.75% | $396.48 | $502.42 | $481,049,184 | $609,586,186 | +$128,537,002 | +26.72% |
| Tango Therapeutics Inc. (TNGX) | Equity | -30.35% | 9,097,411 | 1.09% | $20.92 | $20.56 | $190,317,838 | $187,042,770 | -$3,275,068 | -1.72% |
| Tenable Holdings Inc. (TENB) | Equity | +100% | 265,000 | 0.03% | $16.92 | N/A | $4,482,475 | N/A | N/A | N/A |
| Tenet Healthcare Corp. (THC) | Equity | +21.50% | 452,153 | 0.49% | $188.71 | $196.66 | $85,325,793 | $88,920,409 | +$3,594,616 | +4.21% |
| Thermo Fisher Scientific Inc. (TMO) | Equity | +38.67% | 881,485 | 2.48% | $491.53 | $438.34 | $433,276,322 | $386,390,135 | -$46,886,187 | -10.82% |
| The Timken Company (TKR) | Equity | +100% | 51,000 | 0.03% | $100.57 | N/A | $5,129,070 | N/A | N/A | N/A |
| Travere Therapeutics Inc. (TVTX) | Equity | 0% | 12,000 | 0.00% | $29.71 | $42.59 | $356,520 | $511,080 | +$154,560 | +43.35% |
| Tvardi Therapeutics INC | Equity | -50.40% | 21,438 | 0.00% | $3.18 | $0.00 | $68,173 | $0 | -$68,173 | -100% |
| Vaxcyte Inc. (PCVX) | Equity | +25120.00% | 1,261,000 | 0.42% | $58.11 | $52.39 | $73,276,710 | $66,063,790 | -$7,212,920 | -9.84% |
| Veracyte Inc. (VCYT) | Equity | 0% | 7,000 | 0.00% | $32.21 | N/A | $225,470 | N/A | N/A | N/A |
| Westinghouse Air Brake Technologies Corp. (WAB) | Equity | -35.00% | 1,609,403 | 2.30% | $249.91 | $263.98 | $402,205,904 | $424,842,157 | +$22,636,253 | +5.63% |
| Littelfuse Inc. (LFUS) | Equity | +100% | 15,000 | 0.03% | $339.35 | $446.11 | $5,090,250 | $6,691,650 | +$1,601,400 | +31.46% |
| Livanova PLC (LIVN) | Equity | 0% | 6,000 | 0.00% | $63.56 | $70.00 | $381,360 | $420,000 | +$38,640 | +10.13% |
| Mastercard Inc. (MA) | Equity | +151.97% | 435,071 | 1.24% | $499.66 | $494.20 | $217,387,576 | $215,012,088 | -$2,375,488 | -1.09% |
| Merck & Co. Inc. (MRK) | Equity | +100% | 361,000 | 0.25% | $120.29 | $111.40 | $43,424,690 | $40,215,400 | -$3,209,290 | -7.39% |
| Merit Medical Systems Inc. (MMSI) | Equity | 0% | 3,000 | 0.00% | $68.93 | $61.36 | $206,790 | $184,080 | -$22,710 | -10.98% |
| Natera Inc. (NTRA) | Equity | -18.06% | 3,207,366 | 3.67% | $199.99 | $186.36 | $641,441,126 | $597,724,728 | -$43,716,398 | -6.82% |
| Nektar Therapeutics | Equity | +100% | 4,000 | 0.00% | $71.95 | $0.00 | $287,800 | $0 | -$287,800 | -100% |
| Neogenomics Inc. (NEO) | Equity | 0% | 19,000 | 0.00% | $7.42 | N/A | $140,980 | N/A | N/A | N/A |
| Novo Nordisk As (NVO) | Equity | +100% | 782,000 | 0.16% | $36.75 | $44.74 | $28,738,500 | $34,986,680 | +$6,248,180 | +21.74% |
| Nuvalent Inc. (NUVL) | Equity | 0% | 3,000 | 0.00% | $102.45 | $102.30 | $307,350 | $306,900 | -$450 | -0.15% |
| Opus Genetics INC (OCUP) | Equity | +100% | 1,000,000 | 0.03% | $4.55 | N/A | $4,550,000 | N/A | N/A | N/A |
| Piper Sandler Companies | Equity | +100% | 66,000 | 0.03% | $76.55 | N/A | $5,052,300 | N/A | N/A | N/A |
| Precigen Inc. (PGEN) | Equity | 0% | 50,000 | 0.00% | $3.87 | $4.42 | $193,500 | $221,000 | +$27,500 | +14.21% |
| Prime Medicine Inc. (PRME) | Equity | 0% | 1,240,843 | 0.02% | $3.48 | $2.93 | $4,318,134 | $3,635,670 | -$682,464 | -15.80% |
| Progyny Inc. (PGNY) | Equity | 0% | 18,000 | 0.00% | $16.98 | $23.25 | $305,640 | $418,500 | +$112,860 | +36.93% |
| Rio Tinto Group (RIO) | Equity | +100% | 53,800 | 0.03% | $93.29 | $103.66 | $5,019,002 | $5,576,908 | +$557,906 | +11.12% |
| S&P Global Inc. (SPGI) | Equity | +100% | 12,000 | 0.03% | $425.34 | $403.09 | $5,104,080 | $4,837,080 | -$267,000 | -5.23% |
| Stoke Therapeutics Inc. (STOK) | Equity | 0% | 9,000 | 0.00% | $32.56 | N/A | $293,040 | N/A | N/A | N/A |
| Strategy INC | Bond | +100% | 39,500,000 | N/A | $0.83 | N/A | $32,877,339 | N/A | N/A | N/A |
| Summit Midstream Corp. (SMC) | Equity | 0% | 58,214 | 0.01% | $30.24 | $32.13 | $1,760,391 | $1,870,416 | +$110,025 | +6.25% |
| Supernus Pharmaceuticals Inc. (SUPN) | Equity | +100% | 4,000 | 0.00% | $51.69 | N/A | $206,760 | N/A | N/A | N/A |
| Syndax Pharmaceuticals Inc. (SNDX) | Equity | 0% | 10,000 | 0.00% | $23.36 | $20.23 | $233,600 | $202,300 | -$31,300 | -13.40% |
| Teva Pharmaceutical Industries Limited (TEVA) | Equity | +785.00% | 354,000 | 0.06% | $30.12 | $34.28 | $10,662,480 | $12,135,120 | +$1,472,640 | +13.81% |
| UnitedHealth Group Inc. (UNH) | Equity | +13.93% | 1,821,706 | 2.82% | $270.59 | $393.83 | $492,935,427 | $717,442,474 | +$224,507,047 | +45.54% |
| Urogen Pharma Ltd. (URGN) | Equity | 0% | 11,000 | 0.00% | $17.98 | N/A | $197,780 | N/A | N/A | N/A |
| Visa Inc. (V) | Equity | +20.81% | 840,710 | 1.45% | $302.24 | $325.75 | $254,096,190 | $273,861,283 | +$19,765,093 | +7.78% |
| VNet Group Inc. (VNET) | Equity | -90.08% | 623,347 | 0.03% | $8.39 | $10.09 | $5,229,881 | $6,289,571 | +$1,059,690 | +20.26% |
| Vertiv Holdings Co (VRT) | Equity | +100% | 19,000 | 0.03% | $250.58 | $370.94 | $4,761,020 | $7,047,860 | +$2,286,840 | +48.03% |
| Vir Biotechnology Inc. (VIR) | Equity | +100% | 22,000 | 0.00% | $8.96 | N/A | $197,120 | N/A | N/A | N/A |
| Vnet Group INC | Bond | +100% | 45,000,000 | N/A | $0.99 | N/A | $44,515,553 | N/A | N/A | N/A |
| Welltower Inc. (WELL) | Equity | -41.69% | 200,000 | 0.23% | $197.71 | $213.74 | $39,542,000 | $42,748,000 | +$3,206,000 | +8.11% |
| Western Alliance Bancorporation (WAL) | Equity | +100% | 73,000 | 0.03% | $70.85 | $78.60 | $5,172,050 | $5,737,800 | +$565,750 | +10.94% |